- Home
- BECN vs LEGN Comparison
BECN vs LEGN Comparison
Compare BECN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BECN
- LEGN
- Stock Information
- Founded
- BECN 1928
- LEGN 2014
- Country
- BECN United States
- LEGN United States
- Employees
- BECN N/A
- LEGN N/A
- Industry
- BECN RETAIL: Building Materials
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- BECN Consumer Discretionary
- LEGN Health Care
- Exchange
- BECN Nasdaq
- LEGN Nasdaq
- Market Cap
- BECN 7.4B
- LEGN 7.0B
- IPO Year
- BECN 2004
- LEGN 2020
- Fundamental
- Price
- BECN $116.64
- LEGN $39.70
- Analyst Decision
- BECN Buy
- LEGN Strong Buy
- Analyst Count
- BECN 9
- LEGN 12
- Target Price
- BECN $120.17
- LEGN $79.50
- AVG Volume (30 Days)
- BECN 897.4K
- LEGN 976.3K
- Earning Date
- BECN 02-27-2025
- LEGN 03-10-2025
- Dividend Yield
- BECN N/A
- LEGN N/A
- EPS Growth
- BECN N/A
- LEGN N/A
- EPS
- BECN 5.85
- LEGN N/A
- Revenue
- BECN $9,659,100,000.00
- LEGN $520,183,000.00
- Revenue This Year
- BECN $9.53
- LEGN $121.13
- Revenue Next Year
- BECN $4.28
- LEGN $65.25
- P/E Ratio
- BECN $19.94
- LEGN N/A
- Revenue Growth
- BECN 9.89
- LEGN 122.96
- 52 Week Low
- BECN $77.54
- LEGN $30.17
- 52 Week High
- BECN $121.42
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- BECN 50.61
- LEGN 64.82
- Support Level
- BECN $118.00
- LEGN $34.36
- Resistance Level
- BECN $120.18
- LEGN $36.39
- Average True Range (ATR)
- BECN 1.85
- LEGN 1.67
- MACD
- BECN -0.66
- LEGN 0.34
- Stochastic Oscillator
- BECN 8.60
- LEGN 94.68
About BECN Beacon Roofing Supply Inc.
Beacon Roofing Supply Inc manufactures and sells roofing and building materials throughout the United States and Canada. Beacon's key customers consist of contractors, home builders, lumberyards, retailers, wholesale distributors, and building materials suppliers. The company's product portfolio includes both residential and non-residential roofing materials, siding, windows, and waterproofing systems. The majority of revenue is generated from residential and non-residential roofing products. The vast majority of Beacon's revenue comes from the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.